IU Simon Cancer Center researcher receives National Clinical Trial Award


INDIANAPOLIS -- (April 13, 2009) -- Darron R. Brown, MD, professor of medicine in the Division of Infectious Diseases and professor of microbiology and immunology at the Indiana University School of Medicine and a researcher with the Indiana University Melvin and Bren Simon Cancer Center, has been named one of three recipients of the 2009 PhRMA Clinical Trial Exceptional Service Award.

The award honors Dr. Brown’s work as a researcher in the development of Gardisil, the Merck & Co. vaccine against infection by the human papillomavirus, which can cause cervical cancer. Dr. Brown played a key role in the pre-clinical research into Gardisil, including demonstrating the effectiveness of a prototype vaccine, as well the clinical testing of Gardisil.

Worldwide, about 370,000 new cases of cervical cancer are diagnosed annually, with a 50 percent mortality rate.

The award was presented to Dr. Brown April 4 by the Pharmaceutical Research and Manufacturers of America.